0001415889-24-011416.txt : 20240424
0001415889-24-011416.hdr.sgml : 20240424
20240424133009
ACCESSION NUMBER: 0001415889-24-011416
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240423
FILED AS OF DATE: 20240424
DATE AS OF CHANGE: 20240424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Musket David B
CENTRAL INDEX KEY: 0001310611
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34058
FILM NUMBER: 24869458
MAIL ADDRESS:
STREET 1: C/O CONOR MEDSYSTEMS, INC.
STREET 2: 1003 HAMILTON COURT
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CAPRICOR THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001133869
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8840 WILSHIRE BLVD
STREET 2: 2ND FLOOR
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90211
BUSINESS PHONE: (310) 358-3200
MAIL ADDRESS:
STREET 1: 8840 WILSHIRE BLVD
STREET 2: 2ND FLOOR
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90211
FORMER COMPANY:
FORMER CONFORMED NAME: Nile Therapeutics, Inc.
DATE OF NAME CHANGE: 20070920
FORMER COMPANY:
FORMER CONFORMED NAME: SMI PRODUCTS INC
DATE OF NAME CHANGE: 20010206
4
1
form4-04242024_010401.xml
X0508
4
2024-04-23
0001133869
CAPRICOR THERAPEUTICS, INC.
CAPR
0001310611
Musket David B
C/O CAPRICOR THERAPEUTICS, INC.
10865 ROAD TO THE CURE, SUITE 150
SAN DIEGO
CA
92121
true
false
false
false
0
Common Stock
2024-04-23
4
M
0
16156
1.39
A
47692
D
Common Stock
7096
I
Held by Reporting Person's IRA
Stock Option (Right to Buy)
1.39
2024-04-23
4
M
0
856
0
D
2027-01-03
Common Stock
856
0
D
Stock Option (Right to Buy)
1.39
2024-04-23
4
M
0
2750
0
D
2027-01-03
Common Stock
2750
0
D
Stock Option (Right to Buy)
1.39
2024-04-23
4
M
0
1050
0
D
2028-01-02
Common Stock
1050
0
D
Stock Option (Right to Buy)
1.39
2024-04-23
4
M
0
2750
0
D
2028-01-02
Common Stock
2750
0
D
Stock Option (Right to Buy)
1.39
2024-04-23
4
M
0
3000
0
D
2019-08-08
2029-08-08
Common Stock
3000
0
D
Stock Option (Right to Buy)
1.39
2024-04-23
4
M
0
5750
0
D
2029-08-08
Common Stock
5750
0
D
This option was granted on January 3, 2017 and was previously reported as covering 8,560 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
The shares vested 1/48th of the first day of each month, commencing February 1, 2017.
This option was granted on January 3, 2017 and was previously reported as covering 27,500 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
The shares vested 1/12th of the first day of each month, commencing February 1, 2017 with the last 1/12th vesting on December 31, 2017.
This option was granted on January 2, 2018 and was previously reported as covering 10,500 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
The shares vested 1/48th of the first day of each month, commencing February 1, 2018.
This option was granted on January 2, 2018 and was previously reported as covering 27,500 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
The shares vested 1/12th of the first day of each month, commencing February 1, 2018 with the last 1/12th vesting on December 31, 2018.
This option was granted on August 8, 2019 and was previously reported with an exercise price of $3.25 per share, but was adjusted to reflect a share reprice to $1.39 per share that occurred on February 12, 2020.
The shares vested 1/48th of the first day of each month, commencing September 1, 2019.
/s/ Linda Marban, Attorney-in-Fact
2024-04-24